GB1410541A - Concentration of solutions of biological heat sensitive substances - Google Patents
Concentration of solutions of biological heat sensitive substancesInfo
- Publication number
- GB1410541A GB1410541A GB49773A GB49773A GB1410541A GB 1410541 A GB1410541 A GB 1410541A GB 49773 A GB49773 A GB 49773A GB 49773 A GB49773 A GB 49773A GB 1410541 A GB1410541 A GB 1410541A
- Authority
- GB
- United Kingdom
- Prior art keywords
- solution
- ice
- concentrated
- concentrated solution
- impure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000126 substance Substances 0.000 title abstract 4
- 239000013078 crystal Substances 0.000 abstract 4
- 238000001816 cooling Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 abstract 1
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 abstract 1
- 102000015790 Asparaginase Human genes 0.000 abstract 1
- 108010024976 Asparaginase Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
- 102000001974 Hyaluronidases Human genes 0.000 abstract 1
- 102000001399 Kallikrein Human genes 0.000 abstract 1
- 108060005987 Kallikrein Proteins 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- 229940122618 Trypsin inhibitor Drugs 0.000 abstract 1
- 229960003272 asparaginase Drugs 0.000 abstract 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000010586 diagram Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 239000013067 intermediate product Substances 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 150000002960 penicillins Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 238000001953 recrystallisation Methods 0.000 abstract 1
- 238000004064 recycling Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000002753 trypsin inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4853—Kallikrein (3.4.21.34 or 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/02—Foam dispersion or prevention
- B01D19/04—Foam dispersion or prevention by addition of chemical substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/02—Crystallisation from solutions
- B01D9/04—Crystallisation from solutions concentrating solutions by removing frozen solvent therefrom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2204598A DE2204598A1 (de) | 1972-02-01 | 1972-02-01 | Anwendung eines verfahrens zur gefrierkonzentrierung von waessrigen loesungen von arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1410541A true GB1410541A (en) | 1975-10-15 |
Family
ID=5834656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB49773A Expired GB1410541A (en) | 1972-02-01 | 1973-01-04 | Concentration of solutions of biological heat sensitive substances |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3897409A (cg-RX-API-DMAC10.html) |
| JP (1) | JPS4884082A (cg-RX-API-DMAC10.html) |
| AT (1) | AT323319B (cg-RX-API-DMAC10.html) |
| BE (1) | BE794743A (cg-RX-API-DMAC10.html) |
| DE (1) | DE2204598A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2170135B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB1410541A (cg-RX-API-DMAC10.html) |
| NL (1) | NL7301244A (cg-RX-API-DMAC10.html) |
| PL (1) | PL89089B1 (cg-RX-API-DMAC10.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111646923A (zh) * | 2020-06-18 | 2020-09-11 | 山西省分析科学研究院 | 一种冷冻浓缩提纯羟基乙腈的方法 |
| CN113680097A (zh) * | 2013-08-29 | 2021-11-23 | 株式会社明治 | 采用冷冻浓缩法的浓缩制品的制造方法 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8337060B1 (en) | 2011-07-15 | 2012-12-25 | John Kent Frankovich | Bicycle lighting systems and methods |
| US9527540B2 (en) | 2011-07-15 | 2016-12-27 | Revolights, Inc. | Bicycle lighting systems and methods |
| USD685509S1 (en) | 2011-10-12 | 2013-07-02 | Revolights, Inc. | Bicycle lighting system |
| US9227559B2 (en) | 2012-12-31 | 2016-01-05 | Revolights, Inc. | Vehicle lighting control system and method |
| US8956542B1 (en) * | 2013-07-30 | 2015-02-17 | Showa Freezing Plant Co., Ltd. | Method for processing radioactively-contaminated water |
| US10393365B2 (en) | 2017-04-05 | 2019-08-27 | Revolights, Inc. | Wheelchair lighting systems and methods |
-
0
- BE BE794743D patent/BE794743A/xx unknown
-
1972
- 1972-02-01 DE DE2204598A patent/DE2204598A1/de active Pending
-
1973
- 1973-01-04 GB GB49773A patent/GB1410541A/en not_active Expired
- 1973-01-26 US US327108A patent/US3897409A/en not_active Expired - Lifetime
- 1973-01-26 JP JP48010381A patent/JPS4884082A/ja active Pending
- 1973-01-29 NL NL7301244A patent/NL7301244A/xx unknown
- 1973-01-30 AT AT80473A patent/AT323319B/de not_active IP Right Cessation
- 1973-01-31 PL PL1973160494A patent/PL89089B1/pl unknown
- 1973-02-01 FR FR7303558A patent/FR2170135B1/fr not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113680097A (zh) * | 2013-08-29 | 2021-11-23 | 株式会社明治 | 采用冷冻浓缩法的浓缩制品的制造方法 |
| CN111646923A (zh) * | 2020-06-18 | 2020-09-11 | 山西省分析科学研究院 | 一种冷冻浓缩提纯羟基乙腈的方法 |
| CN111646923B (zh) * | 2020-06-18 | 2022-11-15 | 山西省科技资源与大型仪器开放共享中心 | 一种冷冻浓缩提纯羟基乙腈的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| PL89089B1 (cg-RX-API-DMAC10.html) | 1976-10-30 |
| NL7301244A (cg-RX-API-DMAC10.html) | 1973-08-03 |
| US3897409A (en) | 1975-07-29 |
| JPS4884082A (cg-RX-API-DMAC10.html) | 1973-11-08 |
| FR2170135A1 (cg-RX-API-DMAC10.html) | 1973-09-14 |
| BE794743A (fr) | 1973-07-30 |
| AT323319B (de) | 1975-07-10 |
| FR2170135B1 (cg-RX-API-DMAC10.html) | 1977-02-04 |
| DE2204598A1 (de) | 1973-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69006555D1 (de) | Reinigungs- und Trennverfahren für eine Carbonsäure. | |
| GB1446905A (en) | Process and apparatus for manufacture of soft candies | |
| ES386924A1 (es) | Perfeccionamientos en la construccion de plantas utilizablesen la reduccion del contenido en impurezas del agua impura. | |
| GB1397150A (en) | Electrodialytic process for producing itaconic acid and its salts | |
| US3897409A (en) | Freeze concentration of aqueous solutions of heat-labile substances | |
| GB1395651A (en) | Lyophilised serum or plasma and process for its preparation | |
| IE32685B1 (en) | Powdered wort and manufacture of beer therefrom | |
| GB1148615A (en) | Method of purifying organic substances | |
| CA1000221A (en) | Process for the production of 1-malic acid by microbiological fermentation and means suitable for carrying out the same | |
| FR2399467A1 (fr) | Perfectionnements a la fabrication du colorant de betterave | |
| GB1277282A (en) | A process for the purification of 4,4-dihydroxy-diphenyl-2,2-propane or the phenol adduct thereof | |
| JPS5519055A (en) | Separation of micophenolic acid | |
| BE905959A (fr) | Procede de cristallisation par evaporation sous vide, de solutions, notamment de solutions sucrees. | |
| GB1193612A (en) | Crystallization Concentration Process. | |
| GB1223028A (en) | Preparation of carboxylic acids and/or esters | |
| GB1393336A (en) | Purification of beta-napthol by extractive crystallization | |
| IE37494L (en) | Purification of common salt | |
| GB956997A (en) | Improvements relating to the production of fresh water from salt water | |
| SU81843A1 (ru) | Способ окислени сорбита в сорбозу | |
| SU134210A1 (ru) | Способ гидролиза крахмалистого сырь | |
| FR2087962A5 (en) | Continuous crystallisation of sugar | |
| GB1145815A (en) | Method for separating adipic acid from nitric acid oxidation product stream | |
| JPS5320493A (en) | Separation of ribonucleic acid | |
| JPS5212146A (en) | Process for preparation of p- acetylaminobenzene-sufonylchloride | |
| GB1141419A (en) | Process for the crystallization of urea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |